BioPlus Acquisition Corp. announced that it has entered into an agreement for private placement of 640,000 units at a purchase price of $10.00 per unit for gross proceeds of $6,400,000 on June 21, 2021. The transaction will include participation from returning investor Bioplus Sponsor LLC for 420,000 units and Cantor Fitzgerald & Co, Investment Arm for 220,000 units. Each unit consists of one Class A ordinary share and one- fourth of one warrant. Each warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable on the later of 30 days after the completion of our initial business combination or 12 months from the closing of this offering and will expire five years after the completion of our initial business combination or earlier upon redemption or liquidation. Warrants may be exercised only for a whole number of shares. If any fractional interests would be issuable upon exercise of a placement warrant, we will round down to the nearest whole number the number of Class A ordinary shares to be issued to the holder. The placement units and their component securities will not be transferable, assignable or salable until 30 days after the consummation of our initial business combination.